WE'RE WORKING TOGETHER

We are a specimen biobank, a reference laboratory and a CRO. Bringing together the building blocks to partner with our clients and drive science forward.
Together we share one vision, to drive science forward.

Joseph Mauro

President/CEO

Val Adia

CDO

Michael Morris

EVP Operations

Frederick Kiechle, MD, PhD

Medical Director

Magdalyn Elkin

Technology Group Leader

Samantha Ross

BioBanx Group Leader

Adriana Justs

Sales and Marketing Group Leader

Isha Parsana

Procurement Group Leader

William Hill

Data Operations Group Leader

Robin Schwartz

Business Development Associate

Mana Afshar

Biobanx/Reference Lab Technician

Olivia Easter

Biobanx Technician

Marcin Kopczak

Account Manager

Rosario Gordillo

Clinical Project Lead, LATAM

Victoria Beck

Reference Lab Assistant

David Willoughby, PhD

CDx Advisor

Oleg Ovchinnikov, PhD

Bioinformatics Advisor

Benjamin Elkin

Data Analytics Advisor

We work as a team to satisfy our passion for science

5k

For Breast Cancer

Christmas Parties

At the steak house

Happy hour

Dinner and drinks

Halloween

Costume Contest

Nox

Unofficial mascot

Conference Calls

Featuring Stitch

Office Lounge

Morning Coffee

After hours

Office tap

We have partnered with scientists around the world for the future of science.
iStock-952771706
Keep up to date with the latest news from Boca Biolistics
feature image Colorectal Cancer MSI
Colorectal Cancer and MSI

March is colorectal cancer awareness month. Colorectal cancer is the third most common cancer in the U.S. and is often lethal. There is as yet no...

Read More
feature image Data Analytics
Data Analytics and Its Importance to Life Sciences Research

Our modern world runs on data. Sometimes, it might seem like it runs on it too much. In the life sciences, the gathering of large quantities of data,...

Read More
feature image CRO
CROs Can Help Make Clinical Trials More Affordable

Clinical trials are a vital stage in getting a new treatment or therapy to the market, but they have become more and more expensive in recent years....

Read More